Compass Therapeutics Statistics

Total Valuation

CMPX has a market cap or net worth of $293.16 million. The enterprise value is $173.07 million.

Market Cap	293.16M
Enterprise Value	173.07M

Important Dates

The next estimated earnings date is Monday, May 12, 2025, before market open.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

CMPX has 138.28 million shares outstanding. The number of shares has increased by 8.15% in one year.

Current Share Class	138.28M
Shares Outstanding	138.28M
Shares Change (YoY)	+8.15%
Shares Change (QoQ)	-0.70%
Owned by Insiders (%)	4.85%
Owned by Institutions (%)	42.78%
Float	91.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	344.89
Forward PS	n/a
PB Ratio	2.33
P/TBV Ratio	2.34
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	203.61
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.96, with a Debt / Equity ratio of 0.05.

Current Ratio	14.96
Quick Ratio	14.28
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -36.07% and return on invested capital (ROIC) is -25.09%.

Return on Equity (ROE)	-36.07%
Return on Assets (ROA)	-23.81%
Return on Invested Capital (ROIC)	-25.09%
Return on Capital Employed (ROCE)	-43.05%
Revenue Per Employee	$24,286
Profits Per Employee	-$1.41M
Employee Count	35
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +39.47% in the last 52 weeks. The beta is 1.19, so CMPX's price volatility has been higher than the market average.

Beta (5Y)	1.19
52-Week Price Change	+39.47%
50-Day Moving Average	2.36
200-Day Moving Average	1.86
Relative Strength Index (RSI)	55.43
Average Volume (20 Days)	2,734,018

Short Selling Information

The latest short interest is 6.62 million, so 4.79% of the outstanding shares have been sold short.

Short Interest	6.62M
Short Previous Month	4.61M
Short % of Shares Out	4.79%
Short % of Float	7.23%
Short Ratio (days to cover)	7.49

Income Statement

In the last 12 months, CMPX had revenue of $850,000 and -$49.38 million in losses. Loss per share was -$0.36.

Revenue	850,000
Gross Profit	850,000
Operating Income	-56.63M
Pretax Income	-47.24M
Net Income	-49.38M
EBITDA	-56.04M
EBIT	-56.63M
Loss Per Share	-$0.36

Full Income Statement

Balance Sheet

The company has $126.72 million in cash and $6.63 million in debt, giving a net cash position of $120.09 million or $0.87 per share.

Cash & Cash Equivalents	126.72M
Total Debt	6.63M
Net Cash	120.09M
Net Cash Per Share	$0.87
Equity (Book Value)	125.23M
Book Value Per Share	0.91
Working Capital	123.88M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$44.86 million and capital expenditures -$44,000, giving a free cash flow of -$44.90 million.

Operating Cash Flow	-44.86M
Capital Expenditures	-44,000
Free Cash Flow	-44.90M
FCF Per Share	-$0.32

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-6,661.76%
Pretax Margin	-5,808.82%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CMPX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.15%
Shareholder Yield	-8.15%
Earnings Yield	-16.84%
FCF Yield	-15.32%

Analyst Forecast

The average price target for CMPX is $13.57, which is 540.09% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.57
Price Target Difference	540.09%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	241.39%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CMPX has an Altman Z-Score of 4.23 and a Piotroski F-Score of 1.

Altman Z-Score	4.23
Piotroski F-Score	1